29 related articles for article (PubMed ID: 31071490)
1. Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin.
Teran-Saavedra NG; Sarabia-Sainz JA; Velázquez-Contreras EF; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233564
[TBL] [Abstract][Full Text] [Related]
2. Nanostructures Control the Hepatocellular Responses to a Cytotoxic Agent "Cisplatin".
Abdellatef SA; Tange R; Sato T; Ohi A; Nabatame T; Taniguchi A
Biomed Res Int; 2015; 2015():925319. PubMed ID: 26247032
[TBL] [Abstract][Full Text] [Related]
3. Triple-transformable dynamic surroundings for programmed transportation of bio-vulnerable mRNA payloads towards systemic treatment of intractable solid tumors.
Wang Y; Liu J; Cui H; Zhang L; Li Z; Wang X; Wang J; Chen Q; Zhao Y
Biomaterials; 2024 Jun; 311():122677. PubMed ID: 38917704
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy.
Radu ER; Semenescu A; Voicu SI
Polymers (Basel); 2022 Dec; 14(23):. PubMed ID: 36501642
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanomedicines for the treatment of hepatic diseases.
Luo F; Yu Y; Li M; Chen Y; Zhang P; Xiao C; Lv G
J Nanobiotechnology; 2022 Nov; 20(1):488. PubMed ID: 36402994
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Varieties of Polymeric Nanocarriers and Influences of Their Physicochemical Properties on Drug Delivery Profiles.
De R; Mahata MK; Kim KT
Adv Sci (Weinh); 2022 Apr; 9(10):e2105373. PubMed ID: 35112798
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis.
Das SS; Bharadwaj P; Bilal M; Barani M; Rahdar A; Taboada P; Bungau S; Kyzas GZ
Polymers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580366
[TBL] [Abstract][Full Text] [Related]
8. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma.
Turato C; Balasso A; Carloni V; Tiribelli C; Mastrotto F; Mazzocca A; Pontisso P
J Control Release; 2017 Dec; 268():184-197. PubMed ID: 29051062
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactobionamidoethyl methacrylate)-based amphiphiles with ultrasound-labile components in manufacture of drug delivery nanoparticulates for augmented cytotoxic efficacy to hepatocellular carcinoma.
Wang J; Xia Y; Liu H; Xia J; Qian M; Zhang L; Chen L; Chen Q
J Colloid Interface Sci; 2019 Sep; 551():1-9. PubMed ID: 31071490
[TBL] [Abstract][Full Text] [Related]
11.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Responsive Nanoparticulate for Selective Amplification of Chemotherapeutic Potency for Ablation of Solid Tumors.
Xia J; Wang J; Wang X; Qian M; Zhang L; Chen Q
Bioconjug Chem; 2018 Oct; 29(10):3467-3475. PubMed ID: 30185019
[TBL] [Abstract][Full Text] [Related]
13. Collaborative assembly of doxorubicin and galactosyl diblock glycopolymers for targeted drug delivery of hepatocellular carcinoma.
Li J; Zhang Y; Cai C; Rong X; Shao M; Li J; Yang C; Yu G
Biomater Sci; 2020 Jan; 8(1):189-200. PubMed ID: 31821399
[TBL] [Abstract][Full Text] [Related]
14. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
[TBL] [Abstract][Full Text] [Related]
15. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
